VAERS reports by lot

Merck HPV lot 1437Z: VAERS reports

35 VAERS reports list lot 1437Z as a Merck HPV vaccine, received between 2011-03-08 and 2016-06-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
34%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Musculoskeletal2720%
Neurological2519%
General / Systemic (non-local)2317%
Gastrointestinal1511%
Cardiac / Cardiovascular129%
Injection-site / Local reaction97%
Dermatological (non-injection-site)75%
Allergic / Anaphylactic54%
Respiratory54%
Psychiatric / Neuropsychiatric43%
Autoimmune / Immune-mediated32%

Where reports came from

U.S. state of the reporter, where given (top 12).

California11
New York3
Ohio3
Illinois2
Texas2
Georgia1
Maryland1
Hawaii1
Minnesota1
Arizona1
Florida1
North Carolina1

Reports by month received

2011-031
2011-044
2011-055
2011-065
2011-071
2011-0810
2011-092
2011-101
2012-031
2012-061
2013-081
2014-021
2014-091
2016-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.